Kyle Musgrove is a patent trial and appellate lawyer who assists American and international companies of all sizes navigate patent litigation to help bring their products to market. He's litigated cases and provided general intellectual property counsel across a broad spectrum of technology areas, including in the electrical, mechanical, pharmaceutical, and biologics fields.
For each client and each engagement, Kyle makes the investment necessary to understand that client's business and craft a strategy that prioritizes how that client defines success. By addressing intellectual property issues at the front end, Kyle's approach has often facilitated favorable settlements for his clients while avoiding the uncertainty and expense of protracted litigation. He has also helped clients avoid disputes in the first place by assessing potential patent infringement or invalidity issues and, where appropriate, negotiating intellectual property agreements. He also regularly counsels clients on various patent and licensing agreements to help them protect what they own or, in some cases, to provide clients access to technology pursuant to appropriate business terms. Kyle has particular experience helping pharmaceutical companies with Abbreviated New Drug Applications (ANDA) and 505(b)(2) applications.
Kyle has over 25 years of experience in intellectual property litigation and has a strong track record of invalidating patents or clearing companies of infringement allegations, including multiple cases involving brand products with sales exceeding $1 billion per year. Additionally, Kyle has practiced before the United States International Trade Commission and litigated antitrust violations relating to allegations of “sham” litigation brought by patentees.